Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 382

1.

Patterns of medical practice in cystic fibrosis: part II. Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

Konstan MW, Butler SM, Schidlow DV, Morgan WJ, Julius JR, Johnson CA.

Pediatr Pulmonol. 1999 Oct;28(4):248-54.

PMID:
10497373
[PubMed - indexed for MEDLINE]
2.

Patterns of medical practice in cystic fibrosis: part I. Evaluation and monitoring of health status of patients. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

Konstan MW, Butler SM, Schidlow DV, Morgan WJ, Julius JR, Johnson CA.

Pediatr Pulmonol. 1999 Oct;28(4):242-7.

PMID:
10497372
[PubMed - indexed for MEDLINE]
3.

Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function.

Padman R, McColley SA, Miller DP, Konstan MW, Morgan WJ, Schechter MS, Ren CL, Wagener JS; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

Pediatrics. 2007 Mar;119(3):e531-7.

PMID:
17332172
[PubMed - indexed for MEDLINE]
Free Article
4.

Trends in the use of routine therapies in cystic fibrosis: 1995-2005.

Konstan MW, VanDevanter DR, Rasouliyan L, Pasta DJ, Yegin A, Morgan WJ, Wagener JS; Scientific Advisory Group; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

Pediatr Pulmonol. 2010 Dec;45(12):1167-72. doi: 10.1002/ppul.21315. Epub 2010 Aug 17.

PMID:
20717935
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

International practice patterns by age and severity of lung disease in cystic fibrosis: data from the Epidemiologic Registry of Cystic Fibrosis (ERCF).

Koch C, McKenzie SG, Kaplowitz H, Hodson ME, Harms HK, Navarro J, Mastella G.

Pediatr Pulmonol. 1997 Aug;24(2):147-54; discussion 159-61.

PMID:
9292912
[PubMed - indexed for MEDLINE]
6.

Basic therapies in cystic fibrosis. Does standard therapy work?

Marshall BC, Samuelson WM.

Clin Chest Med. 1998 Sep;19(3):487-504, vi. Review.

PMID:
9759551
[PubMed - indexed for MEDLINE]
7.

[Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa].

Derelle J, Bertolo-Houriez E, Marchal F, Weber M, Virion JM, Vidailhet M.

Arch Pediatr. 1998 Apr;5(4):371-7. French.

PMID:
9759155
[PubMed - indexed for MEDLINE]
8.

Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids.

Jaffe A, Balfour-Lynn IM.

Paediatr Drugs. 2002;4(6):381-9. Review.

PMID:
12038874
[PubMed - indexed for MEDLINE]
9.

Association between practice patterns and body mass index percentile in infants and young children with cystic fibrosis.

Padman R, Werk LN, Ramirez-Garnica G, Ye G, Nathanson I.

J Cyst Fibros. 2008 Sep;7(5):385-90. doi: 10.1016/j.jcf.2008.01.005. Epub 2008 Mar 14.

PMID:
18342580
[PubMed - indexed for MEDLINE]
Free Article
11.

Pulmonary deposition of inhaled tobramycin prior to and after respiratory therapy and use of inhaled albuterol in cystic fibrosis patients colonized with Pseudomonas aeruginosa.

Grotta MB, Etchebere EC, Ribeiro AF, Romanato J, Ribeiro MA, Ribeiro JD.

J Bras Pneumol. 2009 Jan;35(1):35-43. English, Portuguese.

PMID:
19219329
[PubMed - indexed for MEDLINE]
Free Article
12.

Cystic fibrosis in adults: diagnostic and therapeutic aspects.

Dalcin Pde T, Abreu E Silva FA.

J Bras Pneumol. 2008 Feb;34(2):107-17. Review. English, Portuguese.

PMID:
18345455
[PubMed - indexed for MEDLINE]
Free Article
13.

Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis.

Ren CL, Pasta DJ, Rasouliyan L, Wagener JS, Konstan MW, Morgan WJ; Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

J Pediatr. 2008 Dec;153(6):746-51. doi: 10.1016/j.jpeds.2008.07.010. Epub 2008 Aug 30.

PMID:
18760805
[PubMed - indexed for MEDLINE]
14.

Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis.

Navarro J, Rainisio M, Harms HK, Hodson ME, Koch C, Mastella G, Strandvik B, McKenzie SG.

Eur Respir J. 2001 Aug;18(2):298-305.

PMID:
11529288
[PubMed - indexed for MEDLINE]
Free Article
15.

Effects of the flutter device on pulmonary function studies among pediatric cystic fibrosis patients.

Padman R, Geouque DM, Engelhardt MT.

Del Med J. 1999 Jan;71(1):13-8.

PMID:
10024754
[PubMed - indexed for MEDLINE]
16.

[Cystic fibrosis: from the child to the adult].

Murris-Espin M, Didier A.

Rev Mal Respir. 2000 Aug;17(3 Pt 2):721-3. French. No abstract available.

PMID:
11076381
[PubMed - indexed for MEDLINE]
17.

Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis.

Talmaciu I, Varlotta L, Mortensen J, Schidlow DV.

Pediatr Pulmonol. 2000 Jul;30(1):10-5.

PMID:
10862157
[PubMed - indexed for MEDLINE]
18.

[Diagnosis and management of cystic fibrosis in children].

Tamalet A, Fauroux B, Clement A.

Rev Mal Respir. 2000 Aug;17(3 Pt 2):725-32. Review. French.

PMID:
11076382
[PubMed - indexed for MEDLINE]
19.

Estimating effectiveness in an observational study: a case study of dornase alfa in cystic fibrosis. The Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

Johnson CA, Butler SM, Konstan MW, Breen TJ, Morgan WJ.

J Pediatr. 1999 Jun;134(6):734-9.

PMID:
10356143
[PubMed - indexed for MEDLINE]
20.

Cystic fibrosis in adults: a changing scene.

Blau H, Livne M, Mussaffi H.

Isr Med Assoc J. 2003 Jul;5(7):491-5.

PMID:
12901245
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk